Location: Home
  • search
  • go
  • Relate News
  • 9/26/2016MicuRx Raises $55M for Phase III Antibiotic Trials
  • 9/26/2016Merck Finds Shortcut for Anticancer Keytruda into China via Medical To...
  • 9/23/2016WuXi Biologics Opens Perfusion Biologics Manufacturing Facility
  • 9/23/2016Hard to Swallow: Emerging Markets Get Tougher for Drugmakers
  • 9/22/2016Recent Executive Moves
  • 9/22/201628 Central Government Agencies Sign MOU for Joint Punishment of Seriou...
  • 9/22/2016IMS: Chinese Retail Pharmacy Sales Up 6.3% in MAT Q2/2016
  • 9/22/2016Updated - China Performance of Pharma MNCs Rebounded in the First Half...
  • 9/21/2016IMS: Chinese Hospital Drug Sales Up 6.2% in MAT Q2/2016
  • 9/21/2016China's First National Gene Bank to Begin Operation
  • 9/20/2016Novo Nordisk Expects to Recover Lost Ground in China with Planned New ...
  • 9/20/2016US Court Threw Out China Vitamin C Price Fixing Decision
  • 9/20/2016CFDA Solicits Public Comments on Draft Rules on Imported Herbal Crude ...
  • 9/19/2016LG Life Science Introduces Filler with Lidocaine in China
  • 9/19/2016Chinese Antibiotic Developer TenNor Therapeutic Secures $25M Funding
  • 9/19/2016Itochu, CITIC Eye Hospital Management JV
  • 9/19/2016Korean Pharma Huons Places Big Bet on China with First Overseas Plant ...
  • 9/19/2016NDRC Official Lays Out Directions of Medical Service Price Reform
  • 9/19/2016NHFPC and MOF Issue Notice to Advance Overall Reform of County Level P...
  • 9/19/2016Review of R&D Investments of Listed Chinese Pharma Companies in H1
  • 9/19/2016Data Snapshot: Top Ten Domestically-listed Pharma Cos by R&D Inves...
  • 9/16/2016Lung Cancer Most Common Cancer in China: Air Pollution Taking Its Toll
  • 9/16/2016Recent Executive Movements
  • 9/16/2016Revised Draft Cyber Security Law May Significantly Impact Multinationa...
  • 9/14/2016Sanofi to Center Its China Business Strategy on Primary Healthcare in ...
  • 9/14/2016CFDA Seeks Comments on New Review Guideline for Equivalence Studies
  • 9/14/2016CFDA Releases New Announcement for Excessively-Supplied Drug Products
  • 9/14/2016CDE Grants Priority Review Status to 17 Drug Registration Applications
  • 9/13/2016ICH and PIC/S: No Expectations for China to Join Despite Ongoing Talks...
  • 9/13/2016China's Vcanbio Opens Two R&D Subsidiaries in Boston
  • Page:403/790 Total number of articles:23683: [First][<<] [401] [402] [403] [404] [405] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group